230 related articles for article (PubMed ID: 19902306)
1. Primary malignant giant-cell tumor of bone has high survival rate.
Domovitov SV; Healey JH
Ann Surg Oncol; 2010 Mar; 17(3):694-701. PubMed ID: 19902306
[TBL] [Abstract][Full Text] [Related]
2. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
3. [Case analysis on treatment and recurrence of giant cell tumor of bone].
Zhang Z; Zhu B; Sun T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
[TBL] [Abstract][Full Text] [Related]
4. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
5. Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone.
Suzuki Y; Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Nakashima H; Ishiguro N
Knee; 2007 Oct; 14(5):369-74. PubMed ID: 17601737
[TBL] [Abstract][Full Text] [Related]
6. Giant Cell Tumor (tumor gigantocellularis, osteoclastoma) - epidemiology, diagnosis, treatment.
Karpik M
Ortop Traumatol Rehabil; 2010; 12(3):207-15. PubMed ID: 20675862
[TBL] [Abstract][Full Text] [Related]
7. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome?
Wysocki RW; Soni E; Virkus WW; Scarborough MT; Leurgans SE; Gitelis S
Clin Orthop Relat Res; 2015 Feb; 473(2):706-15. PubMed ID: 25472928
[TBL] [Abstract][Full Text] [Related]
8. [Multicentric giant cell tumor: clinical analysis of 9 cases].
Li X; Guo W; Yang RL; Yang Y
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(45):3602-5. PubMed ID: 24534311
[TBL] [Abstract][Full Text] [Related]
9. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in giant cell tumors of bone.
Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M
Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593
[TBL] [Abstract][Full Text] [Related]
11. Functional outcome of en bloc excision and osteoarticular allograft replacement with the Sauve-Kapandji procedure for Campanacci grade 3 giant-cell tumor of the distal radius.
Szabo RM; Anderson KA; Chen JL
J Hand Surg Am; 2006 Oct; 31(8):1340-8. PubMed ID: 17027797
[TBL] [Abstract][Full Text] [Related]
12. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
13. Surgical consideration for benign bone tumors.
Eyesan SU; Idowu OK; Obalum DC; Nnodu OE; Abdulkareem FB
Niger J Clin Pract; 2011; 14(2):146-50. PubMed ID: 21860128
[TBL] [Abstract][Full Text] [Related]
14. Giant cell tumor of bone.
Mendenhall WM; Zlotecki RA; Scarborough MT; Gibbs CP; Mendenhall NP
Am J Clin Oncol; 2006 Feb; 29(1):96-9. PubMed ID: 16462511
[TBL] [Abstract][Full Text] [Related]
15. [The analysis of the treatment of giant cell tumor of the pelvis and sacrum].
Guo W; Tang XD; Li X; Ji T; Sun X
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):501-5. PubMed ID: 18785558
[TBL] [Abstract][Full Text] [Related]
16. [The surgical treatment of primary malignant bone tumors of pelvis].
Ding Y; Niu XH; Zhang Q; Ma K; Liu WF
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):886-90. PubMed ID: 19035144
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the factors affecting the recurrence of giant cell tumor of bone].
Guo QC; Shen JN; Wang J; Huang G; Zou CY; Jin S; Yin JQ; Liao WM
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(12):797-800. PubMed ID: 16889722
[TBL] [Abstract][Full Text] [Related]
18. Giant cell tumor of the mobile spine: a review of 49 cases.
Boriani S; Bandiera S; Casadei R; Boriani L; Donthineni R; Gasbarrini A; Pignotti E; Biagini R; Schwab JH
Spine (Phila Pa 1976); 2012 Jan; 37(1):E37-45. PubMed ID: 22179322
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for recurrence of giant cell tumours of bone.
Siddiqui MA; Seng C; Tan MH
J Orthop Surg (Hong Kong); 2014 Apr; 22(1):108-10. PubMed ID: 24781627
[TBL] [Abstract][Full Text] [Related]
20. Decision making in primary sacral tumors.
Puri A; Agarwal MG; Shah M; Srinivas CH; Shukla PJ; Shrikhande SV; Jambhekar NA
Spine J; 2009 May; 9(5):396-403. PubMed ID: 19059810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
